Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UGCG | Q16739 | 15/20 | 0.40 |
| ▸ | GBA2 | Q9HCG7 | 15/20 | 0.40 |
| ▸ | GBA1 | P04062 | 15/20 | 0.40 |
| ▸ | LCT | P09848 | 2/20 | 0.38 |
| ▸ | SI | P14410 | 2/20 | 0.38 |
| ▸ | MGAM | O43451 | 1/20 | 0.38 |
| ▸ | GUSB | P08236 | 2/20 | 0.38 |
| ▸ | GLB1 | P16278 | 1/20 | 0.36 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.36 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31163940 | 0.83 | UGCG (0.55) | UGCGGBA2GBA1LCTSI | |
| SCHEMBL31163884 | 0.83 | UGCG (0.54) | UGCGGBA2GBA1LCTSI | |
| SCHEMBL31163877 | 0.74 | GUSB (0.44) | UGCGGBA2GBA1LCTSI | |
| SCHEMBL31163895 | 0.73 | UGCG (0.56) | UGCGGBA2GBA1LCTSI | |
| SCHEMBL31163935 | 0.71 | UGCG (0.48) | UGCGGBA2GBA1LCTSI | |
| SCHEMBL31163695 | 0.70 | UGCG (0.68) | UGCGGBA2GBA1LCTSI | |
| SCHEMBL31163887 | 0.68 | UGCG (0.72) | UGCGGBA2GBA1LCTSI | |
| SCHEMBL31163766 | 0.68 | UGCG (0.55) | UGCGGBA2GBA1LCTSI | |
| SCHEMBL31163852 | 0.68 | UGCG (0.68) | UGCGGBA2GBA1LCTSI | |
| SCHEMBL31163830 | 0.66 | UGCG (0.73) | UGCGGBA2GBA1LCTSI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024179491-A1 | GBA1 AND GCS DUAL MODULATOR | ONO PHARMACEUTICAL CO., LTD. (JP) | 2024-09-06 | — | — | WO | disclosed |